PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy7 anti-mouse CD284 (TLR4), 100 μg
PE/Cy7 anti-mouse CD284 (TLR4), 25 μg
PE/Cy7 anti-mouse CD3, 100 μg
PE/Cy7 anti-mouse CD3, 25 μg
PE/Cy7 anti-mouse CD301 (MGL1/MGL2), 100 μg
PE/Cy7 anti-mouse CD301 (MGL1/MGL2), 25 μg
PE/Cy7 anti-mouse CD301a (MGL1), 100 μg
PE/Cy7 anti-mouse CD301a (MGL1), 25 μg
PE/Cy7 anti-mouse CD301b (MGL2), 100 μg
PE/Cy7 anti-mouse CD301b (MGL2), 25 μg
PE/Cy7 anti-mouse CD304 (Neuropilin-1), 100 μg
PE/Cy7 anti-mouse CD304 (Neuropilin-1), 25 μg
PE/Cy7 anti-mouse CD309 (VEGFR2, Flk-1), 100 μg
PE/Cy7 anti-mouse CD309 (VEGFR2, Flk-1), 25 μg
PE/Cy7 anti-mouse CD31, 100 μg